A new pilot Medicaid program — GENEROUS — combines centralized pharmaceutical-coverage negotiations with most-favored-nation pricing in an effort to lower drug costs, but it has some limitations.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results